搜索结果: 1-15 共查到“内科学 drug”相关记录23条 . 查询时间(0.125 秒)
2017年结核药物发现和发展高登研究研讨会（The Gordon Research Seminar on Tuberculosis Drug Discovery and Development）
Tuberculosis Drug Discovery
2017/3/7
Applications for this meeting must be submitted by May 27, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be st...
Patients’ Willingness to Discuss Trade-offs to Lower Their Out-of-Pocket Drug Costs
diabetes drug costs
2014/12/11
Patients’ Willingness to Discuss Trade-offs to Lower Their Out-of-Pocket Drug Costs.
Researchers engineer 'Cas9' animal models to study disease and inform drug discovery
animal drug disease
2014/10/9
Cambridge, Mass. September 25th, 2014 — Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system ...
The University of Queensland research may lead to drug to fight leukaemia（图）
leukaemia leukaemia cells
2014/7/7
A molecular ‘target’ that could lead to a drug to fight leukaemia is in the sights of a team of University of Queensland researchers.
汕头大学医学院药理学精品课程 Drug Affecting hematopoiesis system
汕头大学 医学院 药理学 精品课程 Drug Affecting hematopoiesis system
2013/11/7
汕头大学医学院药理学精品课程 Drug Affecting hematopoiesis system。
Latent and Active Tuberculosis:Evaluation of Injecting Drug Users
Latent Tuberculosis Drug Users Tuberculin
2015/10/8
Background: There is a high risk of tuberculosis (TB) infection among injecting drug users (IDUs).
Antimicrobial Drug Resistance: Burden, Outcomes, Economics, and Antibiotic Stewardship
Antimicrobial Drug Resistance Burden Outcomes Economics Antibiotic Stewardship
2011/4/1
Antimicrobial resistance has become a major health problem worldwide, but marked variations in resistance profiles of bacterial pathogens are found among countries and in different patient settings, e...
Drug-Eluting Stent Fracture within 6 Days after Stent Implantation
Drug-eluting stent Fracture Implantation
2015/9/22
A 63-year-old woman with typical chest pain referred to our center. Her risk factors were hypertension (HTN), hyperlipidemia (HLP), diabetic mellitus (DM), and smoking. Coronary angiography (CAG) reve...
Comparison of Physicians' Compliance, Clinical Efficacy, and Drug Cost before and after Introduction of Asthma Prevention and Management Guidelines in Japan (JGL2003)
asthma management compliance drug cost guideline JGL
2010/11/12
The JGL2003 was judged to have improved criteria, which thus resulted in the high compliance of physicians with the guidelines, in the remission of asthma symptoms and in the reduction in the total an...
Left-Sided Endocarditis Associated with Multi-Drug Resistance Acinetobacter Lwoffii
Acinetobacter Drug resistance multiple Endocarditis
2009/11/25
Acinetobacter lwoffii, an important nosocomial pathogen, is a gram-negative aerobic bacillus that is a component of the normal flora on the skin, oropharynx, and perineum of about 20-25% of healthy in...
Second-Line Drug Susceptibilities of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Aegean Region - Turkey
Mycobacterium tuberculosis multidrug-resistant tuberculosis (MDR-TB) second-line drugs susceptibility tests extensively drug-resistant tuberculosis (XDR-TB)
2009/6/16
Aim: The emergence of multidrug-resistant tuberculosis (MDR-TB) is increasing, and the standard short-course regimen used for the treatment of TB is likely to be ineffective against MDR-TB, leading to...
Food and Drug Administration Requests Boxed Warning for Contrast Agents Used to Improve MRI Images
boxed warning magnetic resonance imaging liver disease
2007/5/24
May 23, 2007，The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhanc...
Food and Drug Administration Approves Product to Treat Common Bleeding Disorder
Humate-P von Willebrand disease bleeding
2007/4/28
April 27, 2007，The U.S. Food and Drug Administration (FDA) today approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surge...
food and drug administration Licenses First Biologic Product to Prevent Hepatitis B Reinfection in Liver Transplant Patients
hepatitis B immune liver cancer Liver transplant
2007/4/11
April 6, 2007,The U.S. Food and Drug Administration (FDA) today announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is the...
food and drug administration Approves First-of-its-Kind Drug to Treat Rare Blood Disorder
hemoglobinuria blood disorder
2007/3/30
March 16, 2007，The U.S. Food and Drug Administration (FDA) today approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood d...